News

January 14th, 2021

Exploring the potential of DUBs and neglected tropical diseases

June 17th, 2020

Ubiquigent Continues Drug Discovery Collaboration with Bristol Myers Squibb

April 30th, 2020

COVID-19 Update: Ubiquigent fully operational

January 30th, 2020

DUBprofiler-Cell™ - target validation and compound-target engagement

October 30th, 2019

LEO Pharma Enters into Option Agreement with Ubiquigent for Access to Novel Compounds

October 21st, 2019

Targeted Protein Degradation